Micaela D Garcia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Micaela D Garcia has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Alan Marcelo Szalai
Centro de Investigaciones en Bionanociencias (CIBION), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Godoy Cruz 2390, C1425FQD Ciudad Autónoma de Buenos Aires, Argentina
1 shared publication - Antonia Marin-Burgin
Instituto de Investigación en Biomedicina de Buenos Aires (IBioBA)-CONICET-Partner Institute of the Max Planck Society
1 shared publication - Cayetana Arnaiz
Department of Cell and Developmental Biology, Vanderbilt University
1 shared publication - Clara Gaguine
Instituto de Investigación en Biomedicina de Buenos Aires IBioBA (MPSP-CONICET), Partner Institute of the Max Planck Society, Buenos Aires, Argentina
1 shared publication - Fernando Daniel Stefani
Centro de Investigaciones en Bionanociencias (CIBION), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina
1 shared publication - Gonzalo Escalante
Centro de Investigaciones en Bionanociencias (CIBION), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina
1 shared publication
Latest Publications
- Open Access
Tau isoforms modulate the axon initial segment controlling axonal trafficking and neuronal excitability
The axon initial segment (AIS) is a specialized neuronal compartment integrating action potential initiation with selective control of axonal trafficking. The microtubule-associated protein tau is a central regulator of cytoskeletal organization and transport, yet how distinct tau isoforms contribute to AIS development and function remains unclear. Here, we examined the role of tau isoform relative abundance in regulating AIS establishment, maturation, excitability, and transport selectivity using murine primary neurons and human induced pluripotent stem cell (hiPSC)-derived neurons combined with super-resolution imaging, electrophysiology, and live trafficking assays. We found that tau expression levels and isoform content modulate the timing and robustness of AIS maturation. In murine neurons, tau deficiency or predominance of 3-repeat (3R) tau delays Ankyrin-G accumulation and AIS stabilization without preventing AIS formation. hiPSC-derived neurons display an intrinsic AIS developmental program accompanied by progressive changes in tau isoform content. Super-resolution DNA-PAINT reveals that endogenous tau decorates axonal microtubules in discrete nanoclusters with compartment-specific distributions. Modulation of the endogenous 3R/4R tau balance in hiPSC-derived neurons shows that isoform composition, independently of tau levels, regulates AIS positioning and Ankyrin-G organization. Functionally, shifts towards 3R-tau reduce sodium currents, impairs action potential firing, and alters lysosomal transport dynamics within the AIS. Together, these findings identify tau isoform balance as a developmental regulator of AIS maturation, linking cytoskeletal organization to neuronal excitability and transport gating. Because the aberrant alternative tau splicing of exon 10 is a defining feature of primary tauopathies, our results provide mechanistic insight into how imbalanced tau isoforms may contribute to neuronal dysfunction. Significant Statement: The axon initial segment (AIS) plays a central role in brain function by integrating action potential initiation with selective control of axonal trafficking. Disruption of tau splicing, resulting in altered ratios of tau isoforms, is a defining feature of several neurodegenerative diseases, yet its functional consequences remain poorly understood. Here, we show that balanced tau isoform expression is required for proper AIS maturation, neuronal excitability, and transport selectivity. By combining a human neuronal model, super-resolution imaging, electrophysiology, and live transport analysis, our work identifies tau isoform balance as a key regulator of AIS development. These findings provide mechanistic insight into how early tau dysregulation may initiate neuronal dysfunction in tauopathies and highlight the AIS as a potential therapeutic target.
Open AccessTau isoforms modulate the axon initial segment controlling axonal trafficking and neuronal excitability
The axon initial segment (AIS) is a specialized neuronal compartment integrating action potential initiation with selective control of axonal trafficking. The microtubule-associated protein tau is a central regulator of cytoskeletal organization and transport, yet how distinct tau isoforms contribute to AIS development and function remains unclear. Here, we examined the role of tau isoform relative abundance in regulating AIS establishment, maturation, excitability, and transport selectivity using murine primary neurons and human induced pluripotent stem cell (hiPSC)-derived neurons combined with super-resolution imaging, electrophysiology, and live trafficking assays. We found that tau expression levels and isoform content modulate the timing and robustness of AIS maturation. In murine neurons, tau deficiency or predominance of 3-repeat (3R) tau delays Ankyrin-G accumulation and AIS stabilization without preventing AIS formation. hiPSC-derived neurons display an intrinsic AIS developmental program accompanied by progressive changes in tau isoform content. Super-resolution DNA-PAINT reveals that endogenous tau decorates axonal microtubules in discrete nanoclusters with compartment-specific distributions. Modulation of the endogenous 3R/4R tau balance in hiPSC-derived neurons shows that isoform composition, independently of tau levels, regulates AIS positioning and Ankyrin-G organization. Functionally, shifts towards 3R-tau reduce sodium currents, impairs action potential firing, and alters lysosomal transport dynamics within the AIS. Together, these findings identify tau isoform balance as a developmental regulator of AIS maturation, linking cytoskeletal organization to neuronal excitability and transport gating. Because the aberrant alternative tau splicing of exon 10 is a defining feature of primary tauopathies, our results provide mechanistic insight into how imbalanced tau isoforms may contribute to neuronal dysfunction. Significant Statement: The axon initial segment (AIS) plays a central role in brain function by integrating action potential initiation with selective control of axonal trafficking. Disruption of tau splicing, resulting in altered ratios of tau isoforms, is a defining feature of several neurodegenerative diseases, yet its functional consequences remain poorly understood. Here, we show that balanced tau isoform expression is required for proper AIS maturation, neuronal excitability, and transport selectivity. By combining a human neuronal model, super-resolution imaging, electrophysiology, and live transport analysis, our work identifies tau isoform balance as a key regulator of AIS development. These findings provide mechanistic insight into how early tau dysregulation may initiate neuronal dysfunction in tauopathies and highlight the AIS as a potential therapeutic target.